Mirabegron and Melaena - a phase IV clinical study of FDA data

Summary:

Melaena is reported as a side effect among people who take Mirabegron (mirabegron), especially for people who are female, 60+ old, have been taking the drug for 1 - 6 months also take Amlodipine, and have Depression.

The phase IV clinical study analyzes which people have Melaena when taking Mirabegron. It is created by eHealthMe based on reports of 5,378 people who have side effects when taking Mirabegron from the FDA, and is updated regularly.

What is Mirabegron?

Mirabegron has active ingredients of mirabegron. It is often used in urge incontinence. eHealthMe is studying from 5,414 Mirabegron users. Check the latest studies of Mirabegron.

What is Melaena?

Melaena (the passage of black, tarry stools) is found to be associated with 1,303 drugs and 1,475 conditions by eHealthMe. Check the latest studies of Melaena.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 28, 2026

5,378 people reported to have side effects when taking Mirabegron.
Among them, 20 people (0.37%) have Melaena.

Among these 20 people:

How long have people been on Mirabegron when they have Melaena? *

What is the gender of people who have Melaena when taking Mirabegron? *

female: 68.42 %
male: 31.58 %

What is the age of people who have Melaena when taking Mirabegron? *

What are other drugs people take besides Mirabegron? *

What are other side effects people have besides Melaena? *

Indigestion: 8 people, 40.00%
Small Intestinal Haemorrhage (bleeding from small intestine): 8 people, 40.00%
Gastrointestinal Haemorrhage (bleeding gastrointestinal tract): 5 people, 25.00%
Fatigue (feeling of tiredness): 4 people, 20.00%
Gastritis Erosive (a break in the surface layer of the membrane lining the stomach with infection): 4 people, 20.00%
Weight Decreased: 2 people, 10.00%
Headache (pain in head): 2 people, 10.00%
Haematuria (presence of blood in urine): 2 people, 10.00%
Haematochezia (passage of stools containing blood): 2 people, 10.00%
Haematemesis (vomiting of blood): 2 people, 10.00%

What are the existing conditions these people have? *

Depression: 3 people, 15.00%
High Blood Cholesterol: 2 people, 10.00%
Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 2 people, 10.00%
Prostate Cancer: 2 people, 10.00%
Pneumonia: 2 people, 10.00%
Osteoporosis (bones weak and more likely to break): 2 people, 10.00%
Fungal Infection: 2 people, 10.00%
Urination - Painful: 1 person, 5.00%
Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 1 person, 5.00%
Bladder Cancer: 1 person, 5.00%

* Approximation only. Some reports may have incomplete information.

Do you take Mirabegron and have Melaena?

- Check whether Melaena is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Mirabegron:

Mirabegron (5,414 reports)

Melaena treatments and more:

Melaena (29,850 reports)

Browse all side effects of Mirabegron:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Melaena:

Melaena (1,303 drugs)

Browse all the conditions that are associated with Melaena:

Melaena (1,475 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on mirabegron (the active ingredients of Mirabegron) and Mirabegron (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.